Alternatively, other alterations trigger progression to MDS and sAML: either monosomy 7q or duplication of 3q which contains the secondary oncogene RUNX1. Both of these chromosomal abnormalities occur after bone marrow cells enter the blast phase [110]. Here, RUNX1 is linked to myelodysplastic syndrome.